ArticleFrontiers in immunology2024

The combination treatment of RC48 and STAT3 inhibitor acts as a promising therapeutic strategy for basal bladder cancer.

Jingxian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.